The function of 2.2. DC-CIK cells are not limited by MHC and other factors in recognizing and killing tumor cells, so they have a broad-spectrum anti-tumor effect and can be applied to the treatment of tumors at different stages. Kill the residual tiny lesions and cancer cells in hemolymph, and restore the cancer-killing immunity of patients.
3.CTL immunotherapy of CTL cells is to use lymphocytes in their own venous blood to differentiate and expand into CTL cells with strong lethality, thus eliminating viruses or killing tumors.
4.CIK cell therapy
Characteristics of (1)CIK cells: strong killing activity, far superior to traditional LAK cells and cytokines such as interferon-γ and interleukin -2;
(2) Advantages 2)CIK cell therapy technology: it can remove residual cancer cells and tiny lesions after surgery, radiotherapy and chemotherapy, and prevent recurrence and metastasis;
5. The role of γδT in treating cells: γδT cells can kill target cells that are sensitive and insensitive to NK cells, and γ δ T cells can dissolve various tumors, recognize tumor antigens and play an immune monitoring role.
6. Mixed lymphocyte therapy: CIK cells, DC-CIK cells, natural killer cells, tumor infiltrating lymphocytes, cytotoxic T lymphocytes and γδT cells are mixed and cultured. 1.γδT medium group
2.NKT medium set
3.CTL media set
4.NK media set